Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy

Details for Australian Patent Application No. 2010242792 (hide)

Owner Genomic Health Inc.

Inventors Shak, Steven; Watson, Drew; Li, Xitong; Lee, Lawrence; Langone, Kim

Agent FB Rice

Pub. Number AU-A-2010242792

PCT Pub. Number WO2010/127322

Priority 61/239,420 02.09.09 US; 61/174,890 01.05.09 US

Filing date 30 April 2010

Wipo publication date 4 November 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/48 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/127322 Priority application(s): WO2010/127322

2 February 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Shak, Steven; Watson, Drew; Li, Xitong; Lee, Lawrence and Clark-Langone, Kim

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010242795-Spinal stabilization devices, systems and methods

2010242789-Organisms for the production of 1,3-butanediol